Transepithelial photorefractive keratectomy - an analysis of the solutions offered by the industry nowadays
- PMID: 40698097
- PMCID: PMC12277988
- DOI: 10.22336/rjo.2025.26
Transepithelial photorefractive keratectomy - an analysis of the solutions offered by the industry nowadays
Abstract
Purpose: To review and compare the current commercial solutions for transepithelial photorefractive keratectomy (TransPRK) offered by leading excimer laser manufacturers-SCHWIND eye-tech-solutions (AMARIS with SmartPulse), Alcon (WaveLight EX500), and Bausch + Lomb Technolas (TENEO 317), with a focus on technology, treatment protocols, and clinical outcomes.
Background: TransPRK, a no-touch surface ablation technique, eliminates mechanical or alcohol-based epithelial removal by using the excimer laser to ablate both epithelium and stromal tissue in a single step. This approach offers advantages, including lower epithelial trauma, reduced risk of infection, and faster epithelial healing. Industry innovation has significantly improved TransPRK outcomes through refined epithelial mapping, high-speed ablation, and advanced eye-tracking systems.All three platforms-SCHWIND AMARIS, WaveLight EX500, and Technolas TENEO-offer effective TransPRK capabilities, each with distinctive advantages. SCHWIND currently leads in terms of surface quality and early visual recovery due to SmartPulse Technology. WaveLight EX500 provides high-speed ablation and robust platform integration, while Technolas TENEO offers customizable epithelial profiles and a user-friendly interface.
Conclusion: In summary, modern TransPRK systems provide safe, effective, and increasingly customizable options for correcting myopia and astigmatism. The choice between platforms depends on a range of factors, including surgical goals, patient profile, available technology, and the surgeon's familiarity with the system. As laser platforms continue to evolve, further innovations in epithelial mapping, real-time ablation control, and surface smoothing may continue to enhance the outcomes and expand the indications for TransPRK.
Keywords: CDVA = Corrected distance visual acuity; Excimer laser; LASIK = Laser-Assisted in Situ Keratomileusis; PRK = Photorefractive Keratectomy; PTK = Phototherapeutic Keratectomy; SPT = SmartPulse Technology; SmartPulse; Streamlight; TransEpi PRK; TransPRK; TransPRK = Transepithelial Photorefractive Keratectomy; UDVA = Uncorrected distance visual acuity.
© 2025 The Authors.
Conflict of interest statement
The authors state no conflict of interest.
Similar articles
-
TransPRK in the treatment of low to moderate and high myopia: a comparative study of the clinical outcomes.Sci Rep. 2025 Jul 13;15(1):25327. doi: 10.1038/s41598-025-10445-9. Sci Rep. 2025. PMID: 40653540 Free PMC article.
-
Effect of Astigmatism Treatment With Three Excimer Lasers After Photorefractive Keratectomy.Eye Contact Lens. 2024 Sep 1;50(9):401-405. doi: 10.1097/ICL.0000000000001113. Epub 2024 Jul 9. Eye Contact Lens. 2024. PMID: 38978191
-
Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia.Cochrane Database Syst Rev. 2016 Feb 22;2(2):CD009799. doi: 10.1002/14651858.CD009799.pub2. Cochrane Database Syst Rev. 2016. PMID: 26899152 Free PMC article.
-
Predictors of Visual Acuity Improvement and Supernormal Vision After Refined Single-Step Transepithelial Photorefractive Keratectomy.J Refract Surg. 2019 Dec 1;35(12):771-780. doi: 10.3928/1081597X-20191025-01. J Refract Surg. 2019. PMID: 31830293
-
Laser-assisted subepithelial keratectomy (LASEK) versus laser-assisted in-situ keratomileusis (LASIK) for correcting myopia.Cochrane Database Syst Rev. 2017 Feb 15;2(2):CD011080. doi: 10.1002/14651858.CD011080.pub2. Cochrane Database Syst Rev. 2017. PMID: 28197998 Free PMC article.
References
-
- Way C, Elghobaier MG, Nanavaty MA. Transepithelial photorefractive keratectomy—a narrative review. Eye Vis (Lond) 2023;10(1):16. doi: 10.1186/s40662-023-00316-0. - DOI
-
- Luger MHA, Ewering T, Arba-Mosquera S, Kretz FTA. Clinical outcomes after SmartSurface TransPRK using the SCHWIND Amaris system. Clinical Ophthalmology (Auckland N.Z.) 2021;15:2039–2047. doi: 10.2147/OPTH.S308311. - DOI
-
- Bausch + Lomb Technolas TENEO 317 Model: Manufacturer’s documentation and user experiences https://www.bauschsurgical.com .
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials